Global Vaccine Effort Leans on China to Overcome Setbacks
- China’s Sinopharm and Sinovac to supply doses to Covax program
- Portion of Chinese vaccine doses will be available immediately
This article is for subscribers only.
The campaign to roll out Covid-19 vaccines to the world is turning to China after supply shortages caused a glaring gap in access to life-saving doses.
Two Chinese developers, Sinovac Biotech Ltd. and Sinopharm Group, agreed to sell their shots to the Covax program, pledging millions of doses that will give the global distribution effort a much needed boost. Covax, backed by groups including the World Health Organization, was set up last year to ensure equitable distribution of vaccines, but has fallen short of initial targets.